NuRAN Registers US$70.6M Shelf to Fund 2,000+ Rural African Sites
NUR sits 23% above its 52-week low of $2.24 on elevated volume (14× avg).
Summary
NuRAN Wireless registered a C$100 million (US$70.6 million) base shelf prospectus to fund construction of more than 2,000 additional rural African telecom sites, while disclosing a working capital deficiency and significant dilution risk from its Series A preferred shares.
Key Events · Financing and Capital Events · NUR
-
US$70.6M Shelf Registration
NuRAN filed a base shelf prospectus to offer up to C$100 million (US$70.6 million) of common shares, warrants, units, subscription receipts, and debt securities over a 25-month period.
-
Proceeds Target 2,000+ Sites
Management estimates the proceeds would fund construction of more than 2,000 additional sites from a contracted backlog of approximately 5,092 sites, at an average all-in cost of about $42,000 per site.
-
Working Capital Deficiency
As of June 30, 2026, the company had an estimated working capital deficiency of approximately $11.1 million, including about $16.1 million of current debt obligations.
-
Dilution Risk from Preferred Shares
If the CSE listing ceases, the Series A Convertible Preferred Shares revert to a floating conversion price of 95% of the lowest Nasdaq trade price, with accrued PIK dividends and default premiums becoming convertible.
Analysis · NUR · Technology
NuRAN Wireless filed a base shelf prospectus to raise up to C$100 million (US$70.6 million) over 25 months, primarily to accelerate its Network-as-a-Service rollout in Africa. The company has a contracted backlog of roughly 5,092 sites but has completed only about 5% of that rollout, and it carries a working capital deficiency of approximately $11.1 million as of June 30, 2026. The shelf provides financing flexibility to shift from a sequential, cash-constrained deployment model to a concurrent, larger-scale buildout. However, the filing also discloses significant dilution risk: the Series A Convertible Preferred Shares carry a floating conversion price of 95% of the lowest Nasdaq trade price if the CSE listing ceases, and multiple current directors and officers were subject to cease trade orders in 2026. The shelf is a registration, not an executed sale — no securities have been issued under it yet.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 29.4% of the 2796 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.03%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NUR was trading at $2.75 on NASDAQ in the Technology sector, with a market capitalization of approximately $32.8M. The 52-week trading range was $2.24 to $261.12. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.